Business Description
Neural Therapeutics Inc
NAICS : 541710
SIC : 3741
ISIN : CA64134N2032
Description
Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.4 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -17.6 | |||||
3-Year EPS without NRI Growth Rate | -7.7 | |||||
3-Year FCF Growth Rate | 17 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 16.62 | |||||
9-Day RSI | 29.4 | |||||
14-Day RSI | 35.46 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.39 | |||||
Quick Ratio | 0.39 | |||||
Cash Ratio | 0.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.5 | |||||
EV-to-EBIT | -1.2 | |||||
EV-to-EBITDA | -1.2 | |||||
EV-to-FCF | -4.89 | |||||
Earnings Yield (Greenblatt) % | -83.6 | |||||
FCF Yield % | -24.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neural Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.01 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 94.53 | ||
| 14-Day RSI | 35.46 | ||
| 14-Day ATR (C$) | 0.001376 | ||
| 20-Day SMA (C$) | 0.01375 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range (C$) | 0.01 - 0.035 | ||
| Shares Outstanding (Mil) | 169.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neural Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neural Therapeutics Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neural Therapeutics Inc Frequently Asked Questions
What is Neural Therapeutics Inc(XCNQ:NURL)'s stock price today?
The current price of XCNQ:NURL is C$0.01. The 52 week high of XCNQ:NURL is C$0.04 and 52 week low is C$0.01.
When is next earnings date of Neural Therapeutics Inc(XCNQ:NURL)?
The next earnings date of Neural Therapeutics Inc(XCNQ:NURL) is .
Does Neural Therapeutics Inc(XCNQ:NURL) pay dividends? If so, how much?
Neural Therapeutics Inc(XCNQ:NURL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Neural Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers